These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22612789)

  • 21. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MMR-vaccination of children allergic to eggs].
    Christensen M; Rønne T; Christiansen AH
    Ugeskr Laeger; 1999 Mar; 161(9):1270-2. PubMed ID: 10083824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Is hospital based MMR vaccination for children with egg allergy here to stay?
    Gill D
    Ir Med J; 2010 Mar; 103(3):90. PubMed ID: 20666077
    [No Abstract]   [Full Text] [Related]  

  • 25. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.
    Barlow WE; Davis RL; Glasser JW; Rhodes PH; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Ward JI; Marcy SM; DeStefano F; Chen RT; Immanuel V; Pearson JA; Vadheim CM; Rebolledo V; Christakis D; Benson PJ; Lewis N;
    N Engl J Med; 2001 Aug; 345(9):656-61. PubMed ID: 11547719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric emergency department anaphylaxis: different patterns from adults.
    Braganza SC; Acworth JP; Mckinnon DR; Peake JE; Brown AF
    Arch Dis Child; 2006 Feb; 91(2):159-63. PubMed ID: 16308410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insufficient vaccination status of children with a chronic disease].
    van der Meer H; Kimpen JL
    Ned Tijdschr Geneeskd; 1996 Jul; 140(27):1402-6. PubMed ID: 8766683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent reactions to food among children at paediatric emergency departments: epidemiology of allergic disease.
    Vetander M; Ly DH; Håkansson N; Lilja G; Nilsson C; Östblom E; Wickman M; Bergström A
    Clin Exp Allergy; 2014 Jan; 44(1):113-20. PubMed ID: 24118652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
    Rimple D; Weiss SJ; Brett M; Ernst AA
    Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Food allergy in infants and children: clinical evaluation and management.
    Levy Y; Kornbroth B; Ofer I; Garty BZ; Danon YL
    Isr J Med Sci; 1994 Dec; 30(12):873-9. PubMed ID: 8002267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylaxis management in the pediatric emergency department: opportunities for improvement.
    Russell S; Monroe K; Losek JD
    Pediatr Emerg Care; 2010 Feb; 26(2):71-6. PubMed ID: 20094000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspected acute allergic reactions: analysis of admissions to the Emergency Department of the AOU Maggiore della Carità Hospital in Novara from 2003 to 2007.
    Dantonio C; Galimberti M; Barbone B; Calamari M; Airoldi G; Campanini M; Di Pietrantonj C; Avanzi GC
    Eur Ann Allergy Clin Immunol; 2008 Dec; 40(4):122-9. PubMed ID: 19227647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
    Bernsen RM; van der Wouden JC
    Pediatr Allergy Immunol; 2008 Sep; 19(6):544-51. PubMed ID: 18266826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination-associated anaphylaxis in adults: diagnostic testing ruling out IgE-mediated vaccine allergy.
    Seitz CS; Bröcker EB; Trautmann A
    Vaccine; 2009 Jun; 27(29):3885-9. PubMed ID: 19428162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.